SANBIO
Live / Registered — Registered — international registration renewed (as of 08 Jul 2024)
What this means for you
Registered since 16 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79203359
- Registration number
- 5377414
- Mark type
- Design + words
- Filed
- 26 Oct 2016
- Published for opposition
- 31 Oct 2017
- Registered
- 16 Jan 2018
- Attorney of record
- N. Alexander Nolte
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, veterinary preparations and sanitary preparations for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for regenerative medicine for medical purposes; medicines for treating central nervous system diseases; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for regenerative medicine for medical purposes
- Class 042 — Scientific and technological services: Testing, inspection, research, development and evaluation services for others in the fields of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; consulting services in the field of pharmaceutical research and development; and testing, inspection, research, or development of pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine and medicines for treating central nervous system diseases; conducting clinical trials for others in the field of pharmaceutical products, providing medical and scientific research information in the field of pharmaceutical products, and consulting services in the field of pharmaceutical product research and development; conducting clinical trials for others, providing medical and scientific research information in the field of clinical trials, and consulting services for others in the field of design, planning, and implementation project management of clinical trials; medical research, compiling data for research purposes in the field of medical consultancy, and providing medical research information in the field of pharmaceuticals, gene therapy, cell therapy for medical purposes, regenerative medicine and medicines for treating central nervous system diseases; scientific research and development, scientific research, analysis, and testing in the field of pharmaceutical product development, gene therapy development, cell therapy for medical purposes development, regenerative medicine development and central nervous system diseases therapy development, consulting services in the field of pharmaceutical product research and development, gene therapy research and development, cell therapy for medical purposes research and development, regenerative medicine research and development and central nervous system diseases therapy medicine research and development, and providing scientific research information in the field of pharmaceuticals, gene therapy, cell therapy regenerative medicine and central nervous system diseases therapy medicine
Owner
- SanBio Company Limited, Tokyo, JP
- SanBio Company Limited, Tokyo, JP
- SanBio Company Limited, Tokyo, JP
Prosecution history
- 08 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 08 Jul 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 02 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Oct 2023 — TEAS SECTION 71 & 15 RECEIVED
- 16 Jan 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 Jun 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Apr 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Apr 2018 — FINAL DISPOSITION PROCESSED
- 16 Apr 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Oct 2017 — PUBLISHED FOR OPPOSITION
- 29 Oct 2017 — NOTIFICATION PROCESSED BY IB
- 11 Oct 2017 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 11 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED